{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:13:22Z","timestamp":1794964402578,"version":"4.9.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1084233"],"award-info":[{"award-number":["OPP1084233"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-040933"],"award-info":[{"award-number":["INV-040933"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-064678"],"award-info":[{"award-number":["INV-064678"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010304","name":"Pershing Square Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010304","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Broad Institute Tuberculosis donor group","id":[{"id":"https:\/\/ror.org\/05a0ya142","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We previously reported an antibiotic discovery screening platform that identifies whole-cell active compounds with high sensitivity while simultaneously providing mechanistic insight, necessary for hit prioritization. Named PROSPECT, (PRimary screening Of Strains to Prioritize Expanded Chemistry and Targets), this platform measures chemical-genetic interactions between small molecules and pooled\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    mutants, each depleted of a different essential protein. Here, we introduce Perturbagen CLass (PCL) analysis, a computational method that infers a compound\u2019s mechanism-of-action (MOA) by comparing its chemical-genetic interaction profile to those of a curated reference set of 437 known molecules. In leave-one-out cross-validation, we correctly predict MOA with 70% sensitivity and 75% precision, and achieve comparable results (69% sensitivity, 87% precision) with a test set of 75 antitubercular compounds with known MOA previously reported by GlaxoSmithKline (GSK). From 98 additional GSK antitubercular compounds with unknown MOA, we predict 60 to act via a reference MOA and functionally validate 29 compounds predicted to target respiration. Finally, from a set of ~5,000 compounds from larger unbiased libraries, we identify a novel QcrB-targeting scaffold that initially lacked wild-type activity, experimentally confirming this prediction while chemically optimizing this scaffold. PCL analysis of PROSPECT data enables rapid MOA assignment and hit prioritization, streamlining antimicrobial discovery.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-64662-x","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:05:19Z","timestamp":1762175119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8486-0619","authenticated-orcid":false,"given":"Austin N.","family":"Bond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Orzechowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4423-7870","authenticated-orcid":false,"given":"Ishay","family":"Ben-Zion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Lemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1319-8207","authenticated-orcid":false,"given":"Nathaniel","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Delano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Lorelei","family":"Golas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Nietupski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-2310","authenticated-orcid":false,"given":"Sabine","family":"Ehrt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5120-962X","authenticated-orcid":false,"given":"Eric J.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6178-4329","authenticated-orcid":false,"given":"Christopher M.","family":"Sassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4445-7219","authenticated-orcid":false,"given":"Dirk","family":"Schnappinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Shoresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7069-0291","authenticated-orcid":false,"given":"Diana K.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2640-7453","authenticated-orcid":false,"given":"James E.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0673","authenticated-orcid":false,"given":"Deborah T.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"64662_CR1","unstructured":"WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. (World Health Organization)."},{"key":"64662_CR2","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/S2213-2600(23)00426-5","volume":"12","author":"SM Labuda","year":"2024","unstructured":"Labuda, S. M., Seaworth, B., Dasgupta, S., Goswami, N. D. & Team, B. P. A. M. P. Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis. Lancet Respir. Med. 12, e5\u2013e6 (2024).","journal-title":"Lancet Respir. Med."},{"key":"64662_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29\u201340 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"64662_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tube.2013.09.003","volume":"93","author":"RC Goldman","year":"2013","unstructured":"Goldman, R. C. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?. Tuberculosis (Edinb.) 93, 569\u2013588 (2013).","journal-title":"Tuberculosis (Edinb.)"},{"key":"64662_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/emmm.201201772","volume":"6","author":"B Lechartier","year":"2014","unstructured":"Lechartier, B., Rybniker, J., Zumla, A. & Cole, S. T. Tuberculosis drug discovery in the post-post-genomic era. EMBO Mol. Med. 6, 158\u2013168 (2014).","journal-title":"EMBO Mol. Med."},{"key":"64662_CR6","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1016\/j.cell.2021.06.033","volume":"184","author":"B Bosch","year":"2021","unstructured":"Bosch, B. et al. Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. Cell 184, 4579\u20134592 e4524 (2021).","journal-title":"Cell"},{"key":"64662_CR7","doi-asserted-by":"crossref","unstructured":"DeJesus, M. A. et al. Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis. mBio 8, e02133-16 (2017).","DOI":"10.1128\/mBio.02133-16"},{"key":"64662_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41586-019-1315-z","volume":"571","author":"EO Johnson","year":"2019","unstructured":"Johnson, E. O. et al. Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes. Nature 571, 72\u201378 (2019).","journal-title":"Nature"},{"key":"64662_CR9","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1093\/nar\/gkq1149","volume":"39","author":"JH Kim","year":"2011","unstructured":"Kim, J. H. et al. Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase. Nucleic Acids Res 39, 2210\u20132220 (2011).","journal-title":"Nucleic Acids Res"},{"key":"64662_CR10","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.chembiol.2012.05.020","volume":"19","author":"GL Abrahams","year":"2012","unstructured":"Abrahams, G. L. et al. Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening. Chem. Biol. 19, 844\u2013854 (2012).","journal-title":"Chem. Biol."},{"key":"64662_CR11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/acsinfecdis.6b00150","volume":"2","author":"JC Evans","year":"2016","unstructured":"Evans, J. C. et al. Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis. ACS Infect. Dis. 2, 958\u2013968 (2016).","journal-title":"ACS Infect. Dis."},{"key":"64662_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/6791","volume":"21","author":"G Giaever","year":"1999","unstructured":"Giaever, G. et al. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet 21, 278\u2013283 (1999).","journal-title":"Nat. Genet"},{"key":"64662_CR13","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/bioinformatics\/btx732","volume":"34","author":"J Nelson","year":"2018","unstructured":"Nelson, J. et al. MOSAIC: a chemical-genetic interaction data repository and web resource for exploring chemical modes of action. Bioinformatics 34, 1251\u20131252 (2018).","journal-title":"Bioinformatics"},{"key":"64662_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nature04784","volume":"441","author":"J Wang","year":"2006","unstructured":"Wang, J. et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441, 358\u2013361 (2006).","journal-title":"Nature"},{"key":"64662_CR15","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1371\/journal.ppat.0030092","volume":"3","author":"D Xu","year":"2007","unstructured":"Xu, D. et al. Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathog. 3, e92 (2007).","journal-title":"PLoS Pathog."},{"key":"64662_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/cmdc.201200428","volume":"8","author":"L Ballell","year":"2013","unstructured":"Ballell, L. et al. Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis. Chem. Med. Chem. 8, 313\u2013321 (2013).","journal-title":"Chem. Med. Chem."},{"key":"64662_CR17","doi-asserted-by":"publisher","first-page":"e0142293","DOI":"10.1371\/journal.pone.0142293","volume":"10","author":"MJ Rebollo-Lopez","year":"2015","unstructured":"Rebollo-Lopez, M. J. et al. Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery. PLoS One 10, e0142293 (2015).","journal-title":"PLoS One"},{"key":"64662_CR18","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1128\/AAC.03486-14","volume":"58","author":"K Arora","year":"2014","unstructured":"Arora, K. et al. Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 58, 6962\u20136965 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64662_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nchembio.2420","volume":"13","author":"S Wellington","year":"2017","unstructured":"Wellington, S. et al. A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase. Nat. Chem. Biol. 13, 943\u2013950 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"64662_CR20","doi-asserted-by":"publisher","first-page":"e75245","DOI":"10.1371\/journal.pone.0075245","volume":"8","author":"TR Ioerger","year":"2013","unstructured":"Ioerger, T. R. et al. Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One 8, e75245 (2013).","journal-title":"PLoS One"},{"key":"64662_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1128\/JB.01019-06","volume":"189","author":"J Daniel","year":"2007","unstructured":"Daniel, J., Oh, T. J., Lee, C. M. & Kolattukudy, P. E. AccD6, a member of the Fas II locus, is a functional carboxyltransferase subunit of the acyl-coenzyme A carboxylase in Mycobacterium tuberculosis. J. Bacteriol. 189, 911\u2013917 (2007).","journal-title":"J. Bacteriol."},{"key":"64662_CR22","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1128\/AAC.02574-13","volume":"58","author":"MC Reddy","year":"2014","unstructured":"Reddy, M. C. et al. Structure, activity, and inhibition of the Carboxyltransferase beta-subunit of acetyl coenzyme A carboxylase (AccD6) from Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 58, 6122\u20136132 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64662_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejps.2015.02.017","volume":"72","author":"JP Sridevi","year":"2015","unstructured":"Sridevi, J. P. et al. Identification of potential Mycobacterium tuberculosis topoisomerase I inhibitors: a study against active, dormant and resistant tuberculosis. Eur. J. Pharm. Sci. 72, 81\u201392 (2015).","journal-title":"Eur. J. Pharm. Sci."},{"key":"64662_CR24","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1021\/jm049146p","volume":"48","author":"BL Staker","year":"2005","unstructured":"Staker, B. L. et al. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. J. Med Chem. 48, 2336\u20132345 (2005).","journal-title":"J. Med Chem."},{"key":"64662_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s44320-024-00069-y","volume":"20","author":"LMT Kim","year":"2024","unstructured":"Kim, L. M. T. et al. Correction of a widespread bias in pooled chemical genomics screens improves their interpretability. Mol. Syst. Biol. 20, 1173\u20131186 (2024).","journal-title":"Mol. Syst. Biol."},{"key":"64662_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nmeth.3853","volume":"13","author":"M Hafner","year":"2016","unstructured":"Hafner, M., Niepel, M., Chung, M. & Sorger, P. K. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat. Methods 13, 521\u2013527 (2016).","journal-title":"Nat. Methods"},{"key":"64662_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185\u2013193 (2003).","journal-title":"Bioinformatics"},{"key":"64662_CR28","doi-asserted-by":"crossref","unstructured":"Bond, A. et al. (2025). TB PROSPECT - Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosis. figshare. Dataset.","DOI":"10.1101\/2025.02.15.638392"},{"key":"64662_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1021\/acsinfecdis.9b00373","volume":"6","author":"EO Johnson","year":"2020","unstructured":"Johnson, E. O., Office, E., Kawate, T., Orzechowski, M. & Hung, D. T. Large-Scale Chemical-Genetic Strategy Enables the Design of Antimicrobial Combination Chemotherapy in Mycobacteria. ACS Infect. Dis. 6, 56\u201363 (2020).","journal-title":"ACS Infect. Dis."},{"key":"64662_CR30","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1109\/34.868688","volume":"22","author":"S Jianbo","year":"2000","unstructured":"Jianbo, S. & Malik, J. Normalized cuts and image segmentation. IEEE Trans. Pattern Anal. Mach. Intell. 22, 888\u2013905 (2000).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"64662_CR31","unstructured":"Ng, A., Jordan, M. & Weiss, Y. On Spectral Clustering: Analysis and an algorithm. Adv. Neural Inf. Process. Syst. 14, 849\u2013856 (2001)."},{"key":"64662_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11222-007-9033-z","volume":"17","author":"U von Luxburg","year":"2007","unstructured":"von Luxburg, U. A tutorial on spectral clustering. Stat. Comput. 17, 395\u2013416 (2007).","journal-title":"Stat. Comput."},{"key":"64662_CR33","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell 171, 1437\u20131452 e1417 (2017).","journal-title":"Cell"},{"key":"64662_CR34","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1093\/bioinformatics\/bti499","volume":"21","author":"AM Molinaro","year":"2005","unstructured":"Molinaro, A. M., Simon, R. & Pfeiffer, R. M. Prediction error estimation: a comparison of resampling methods. Bioinformatics 21, 3301\u20133307 (2005).","journal-title":"Bioinformatics"},{"key":"64662_CR35","doi-asserted-by":"crossref","unstructured":"Zampieri, M. et al. High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds. Sci. Transl. Med. 10, eaal3973 (2018).","DOI":"10.1126\/scitranslmed.aal3973"},{"key":"64662_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21614-4","volume":"8","author":"LR Chiarelli","year":"2018","unstructured":"Chiarelli, L. R. et al. A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK. Sci. Rep. 8, 3187 (2018).","journal-title":"Sci. Rep."},{"key":"64662_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1021\/acsinfecdis.7b00006","volume":"3","author":"M Esposito","year":"2017","unstructured":"Esposito, M. et al. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors. ACS Infect. Dis. 3, 428\u2013437 (2017).","journal-title":"ACS Infect. Dis."},{"key":"64662_CR38","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1021\/acsinfecdis.5b00065","volume":"1","author":"SM Batt","year":"2015","unstructured":"Batt, S. M. et al. Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-beta-d-ribose Oxidase. ACS Infect. Dis. 1, 615\u2013626 (2015).","journal-title":"ACS Infect. Dis."},{"key":"64662_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1021\/acsinfecdis.0c00675","volume":"7","author":"S Grover","year":"2021","unstructured":"Grover, S. et al. Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis. ACS Infect. Dis. 7, 141\u2013152 (2021).","journal-title":"ACS Infect. Dis."},{"key":"64662_CR40","doi-asserted-by":"publisher","first-page":"e0121492","DOI":"10.1371\/journal.pone.0121492","volume":"10","author":"G Mugumbate","year":"2015","unstructured":"Mugumbate, G. et al. Mycobacterial dihydrofolate reductase inhibitors identified using chemogenomic methods and in vitro validation. PLoS One 10, e0121492 (2015).","journal-title":"PLoS One"},{"key":"64662_CR41","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1128\/AAC.01920-15","volume":"60","author":"F Sorrentino","year":"2016","unstructured":"Sorrentino, F. et al. Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages. Antimicrob. Agents Chemother. 60, 640\u2013645 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64662_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22228-6","volume":"8","author":"V Trofimov","year":"2018","unstructured":"Trofimov, V. et al. Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets. Sci. Rep. 8, 3939 (2018).","journal-title":"Sci. Rep."},{"key":"64662_CR43","doi-asserted-by":"publisher","first-page":"e60933","DOI":"10.1371\/journal.pone.0060933","volume":"8","author":"MJ Remuinan","year":"2013","unstructured":"Remuinan, M. J. et al. Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6\u2019,7\u2019-dihydrospiro[piperidine-4,4\u2019-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3. PLoS One 8, e60933 (2013).","journal-title":"PLoS One"},{"key":"64662_CR44","doi-asserted-by":"publisher","first-page":"e52951","DOI":"10.1371\/journal.pone.0052951","volume":"7","author":"KA Abrahams","year":"2012","unstructured":"Abrahams, K. A. et al. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB. PLoS One 7, e52951 (2012).","journal-title":"PLoS One"},{"key":"64662_CR45","doi-asserted-by":"publisher","first-page":"15006","DOI":"10.1038\/nmicrobiol.2015.6","volume":"1","author":"JA Cox","year":"2016","unstructured":"Cox, J. A. et al. THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria. Nat. Microbiol 1, 15006 (2016).","journal-title":"Nat. Microbiol"},{"key":"64662_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep38083","volume":"6","author":"JM Thiede","year":"2016","unstructured":"Thiede, J. M. et al. Targeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates. Sci. Rep. 6, 38083 (2016).","journal-title":"Sci. Rep."},{"key":"64662_CR47","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1021\/acsinfecdis.5b00063","volume":"1","author":"A Kumar","year":"2015","unstructured":"Kumar, A. et al. A Focused Screen Identifies Antifolates with Activity on Mycobacterium tuberculosis. ACS Infect. Dis. 1, 604\u2013614 (2015).","journal-title":"ACS Infect. Dis."},{"key":"64662_CR48","doi-asserted-by":"publisher","first-page":"e0067621","DOI":"10.1128\/AAC.00676-21","volume":"65","author":"DA Negatu","year":"2021","unstructured":"Negatu, D. A. et al. Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus. Antimicrob. Agents Chemother. 65, e0067621 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64662_CR49","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1128\/AAC.03229-14","volume":"58","author":"W Li","year":"2014","unstructured":"Li, W. et al. Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 58, 6413\u20136423 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64662_CR50","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1021\/acsinfecdis.9b00048","volume":"5","author":"W Li","year":"2019","unstructured":"Li, W. et al. Direct Inhibition of MmpL3 by Novel Antitubercular Compounds. ACS Infect. Dis. 5, 1001\u20131012 (2019).","journal-title":"ACS Infect. Dis."},{"key":"64662_CR51","doi-asserted-by":"crossref","unstructured":"Berube, B. J. et al. Novel MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis and Synergize with Electron Transport Chain Inhibitors. Antimicrob. Agents Chemother. 63, e00083-19 (2019).","DOI":"10.1128\/AAC.02661-18"},{"key":"64662_CR52","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1021\/jm500131s","volume":"57","author":"K Li","year":"2014","unstructured":"Li, K. et al. Multitarget drug discovery for tuberculosis and other infectious diseases. J. Med Chem. 57, 3126\u20133139 (2014).","journal-title":"J. Med Chem."},{"key":"64662_CR53","doi-asserted-by":"publisher","first-page":"100068","DOI":"10.1016\/j.tcsw.2021.100068","volume":"7","author":"AR Moorey","year":"2021","unstructured":"Moorey, A. R. et al. The multi-target aspect of an MmpL3 inhibitor: The BM212 series of compounds bind EthR2, a transcriptional regulator of ethionamide activation. Cell Surf. 7, 100068 (2021).","journal-title":"Cell Surf."},{"key":"64662_CR54","doi-asserted-by":"publisher","first-page":"e20374","DOI":"10.1371\/journal.pone.0020374","volume":"6","author":"KG Anthony","year":"2011","unstructured":"Anthony, K. G. et al. New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis. PLoS One 6, e20374 (2011).","journal-title":"PLoS One"},{"key":"64662_CR55","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bcp.2011.11.021","volume":"83","author":"M Ciustea","year":"2012","unstructured":"Ciustea, M. et al. Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus. Biochem Pharm. 83, 368\u2013377 (2012).","journal-title":"Biochem Pharm."},{"key":"64662_CR56","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bcp.2013.05.004","volume":"86","author":"Y Lee","year":"2013","unstructured":"Lee, Y. et al. Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones. Biochem Pharm. 86, 222\u2013230 (2013).","journal-title":"Biochem Pharm."},{"key":"64662_CR57","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1021\/cb2004884","volume":"7","author":"PA Mak","year":"2012","unstructured":"Mak, P. A. et al. A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis. ACS Chem. Biol. 7, 1190\u20131197 (2012).","journal-title":"ACS Chem. Biol."},{"key":"64662_CR58","doi-asserted-by":"crossref","unstructured":"O\u2019Malley, T. et al. Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels. Antimicrob. Agents Chemother. 62, e01712-17 (2018).","DOI":"10.1128\/AAC.02439-17"},{"key":"64662_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1021\/ml400088y","volume":"4","author":"GC Moraski","year":"2013","unstructured":"Moraski, G. C. et al. Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and Nanomolar Activity Against Mycobacterium tuberculosis. ACS Med Chem. Lett. 4, 675\u2013679 (2013).","journal-title":"ACS Med Chem. Lett."},{"key":"64662_CR60","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1039\/C6MD00236F","volume":"7","author":"N Phummarin","year":"2016","unstructured":"Phummarin, N. et al. SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc(1) inhibitors. Medchemcomm 7, 2122\u20132127 (2016).","journal-title":"Medchemcomm"},{"key":"64662_CR61","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ijantimicag.2017.08.023","volume":"51","author":"FT Subtil","year":"2018","unstructured":"Subtil, F. T. et al. Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing. Int J. Antimicrob. Agents 51, 378\u2013384 (2018).","journal-title":"Int J. Antimicrob. Agents"},{"key":"64662_CR62","doi-asserted-by":"crossref","unstructured":"Foo, C. S. et al. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis. mBio. 9, e01276-18 (2018).","DOI":"10.1128\/mBio.01276-18"},{"key":"64662_CR63","doi-asserted-by":"publisher","first-page":"e0204121","DOI":"10.1128\/aac.02041-21","volume":"66","author":"C Shelton","year":"2022","unstructured":"Shelton, C. et al. Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 66, e0204121 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64662_CR64","doi-asserted-by":"publisher","first-page":"e1008270","DOI":"10.1371\/journal.ppat.1008270","volume":"16","author":"A Lupien","year":"2020","unstructured":"Lupien, A. et al. New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis. PLoS Pathog. 16, e1008270 (2020).","journal-title":"PLoS Pathog."},{"key":"64662_CR65","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1021\/acsinfecdis.7b00112","volume":"3","author":"NS Chandrasekera","year":"2017","unstructured":"Chandrasekera, N. S. et al. Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB. ACS Infect. Dis. 3, 898\u2013916 (2017).","journal-title":"ACS Infect. Dis."},{"key":"64662_CR66","doi-asserted-by":"publisher","first-page":"102327","DOI":"10.1016\/j.mib.2023.102327","volume":"74","author":"BS Lee","year":"2023","unstructured":"Lee, B. S., Singh, S. & Pethe, K. Inhibiting respiration as a novel antibiotic strategy. Curr. Opin. Microbiol 74, 102327 (2023).","journal-title":"Curr. Opin. Microbiol"},{"key":"64662_CR67","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2180-8-78","volume":"8","author":"AC Brown","year":"2008","unstructured":"Brown, A. C. & Parish, T. Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake. BMC Microbiol 8, 78 (2008).","journal-title":"BMC Microbiol"},{"key":"64662_CR68","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1007\/s00018-011-0753-z","volume":"68","author":"T Grawert","year":"2011","unstructured":"Grawert, T., Groll, M., Rohdich, F., Bacher, A. & Eisenreich, W. Biochemistry of the non-mevalonate isoprenoid pathway. Cell Mol. Life Sci. 68, 3797\u20133814 (2011).","journal-title":"Cell Mol. Life Sci."},{"key":"64662_CR69","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2958.1994.tb02174.x","volume":"14","author":"T Mogi","year":"1994","unstructured":"Mogi, T., Saiki, K. & Anraku, Y. Biosynthesis and functional role of haem O and haem A. Mol. Microbiol 14, 391\u2013398 (1994).","journal-title":"Mol. Microbiol"},{"key":"64662_CR70","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41594-018-0160-3","volume":"25","author":"B Wiseman","year":"2018","unstructured":"Wiseman, B. et al. Structure of a functional obligate complex III(2)IV(2) respiratory supercomplex from Mycobacterium smegmatis. Nat. Struct. Mol. Biol. 25, 1128\u20131136 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"64662_CR71","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s12010-013-0569-4","volume":"172","author":"M Pulaganti","year":"2014","unstructured":"Pulaganti, M., Banaganapalli, B., Mulakayala, C., Chitta, S. K. & C, M. A. Molecular modeling and docking studies of O-succinylbenzoate synthase of M. tuberculosis-a potential target for antituberculosis drug design. Appl Biochem Biotechnol. 172, 1407\u20131432 (2014).","journal-title":"Appl Biochem Biotechnol."},{"key":"64662_CR72","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1128\/AAC.00395-15","volume":"59","author":"B Lechartier","year":"2015","unstructured":"Lechartier, B. & Cole, S. T. Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 59, 4457\u20134463 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64662_CR73","doi-asserted-by":"publisher","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","volume":"286","author":"T Yano","year":"2011","unstructured":"Yano, T. et al. Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J. Biol. Chem. 286, 10276\u201310287 (2011).","journal-title":"J. Biol. Chem."},{"key":"64662_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12956-2","volume":"10","author":"T Beites","year":"2019","unstructured":"Beites, T. et al. Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development. Nat. Commun. 10, 4970 (2019).","journal-title":"Nat. Commun."},{"key":"64662_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8659","volume":"6","author":"J Rybniker","year":"2015","unstructured":"Rybniker, J. et al. Lansoprazole is an antituberculous prodrug targeting cytochrome bc1. Nat. Commun. 6, 7659 (2015).","journal-title":"Nat. Commun."},{"key":"64662_CR76","doi-asserted-by":"publisher","first-page":"e2409747121","DOI":"10.1073\/pnas.2409747121","volume":"121","author":"KP Romano","year":"2024","unstructured":"Romano, K. P. et al. Perturbation-specific transcriptional mapping for unbiased target elucidation of antibiotics. Proc. Natl Acad. Sci. USA 121, e2409747121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64662_CR77","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1021\/jm401411z","volume":"57","author":"G Maggiora","year":"2014","unstructured":"Maggiora, G., Vogt, M., Stumpfe, D. & Bajorath, J. Molecular similarity in medicinal chemistry. J. Med Chem. 57, 3186\u20133204 (2014).","journal-title":"J. Med Chem."},{"key":"64662_CR78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pbiomolbio.2020.02.001","volume":"152","author":"BS Lee","year":"2020","unstructured":"Lee, B. S., Sviriaeva, E. & Pethe, K. Targeting the cytochrome oxidases for drug development in mycobacteria. Prog. Biophys. Mol. Biol. 152, 45\u201354 (2020).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"64662_CR79","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gkr320","volume":"39","author":"TW Backman","year":"2011","unstructured":"Backman, T. W., Cao, Y. & Girke, T. ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res 39, W486\u2013W491 (2011).","journal-title":"Nucleic Acids Res"},{"key":"64662_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44887-9","volume":"9","author":"NP Kalia","year":"2019","unstructured":"Kalia, N. P. et al. Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc(1):aa(3) in Mycobacterium tuberculosis. Sci. Rep. 9, 8608 (2019).","journal-title":"Sci. Rep."},{"key":"64662_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40792-3","volume":"9","author":"RP Bhattacharyya","year":"2019","unstructured":"Bhattacharyya, R. P. et al. Rapid identification and phylogenetic classification of diverse bacterial pathogens in a multiplexed hybridization assay targeting ribosomal RNA. Sci. Rep. 9, 4516 (2019).","journal-title":"Sci. Rep."},{"key":"64662_CR82","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/bioinformatics\/bty784","volume":"35","author":"OM Enache","year":"2019","unstructured":"Enache, O. M. et al. The GCTx format and cmapPy, R, M, J packages: resources for optimized storage and integrated traversal of annotated dense matrices. Bioinformatics 35, 1427\u20131429 (2019).","journal-title":"Bioinformatics"},{"key":"64662_CR83","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res 51, D1373\u2013D1380 (2023).","journal-title":"Nucleic Acids Res"},{"key":"64662_CR84","doi-asserted-by":"publisher","first-page":"588","DOI":"10.5195\/jmla.2018.515","volume":"106","author":"SW Gabrielson","year":"2018","unstructured":"Gabrielson, S. W. SciFinder. J. Med Libr Assoc. 106, 588\u2013590 (2018).","journal-title":"J. Med Libr Assoc."},{"key":"64662_CR85","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox, C. et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res 52, D1265\u2013D1275 (2024).","journal-title":"Nucleic Acids Res"},{"key":"64662_CR86","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1021\/cb300151m","volume":"7","author":"SA Stanley","year":"2012","unstructured":"Stanley, S. A. et al. Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. ACS Chem. Biol. 7, 1377\u20131384 (2012).","journal-title":"ACS Chem. Biol."},{"key":"64662_CR87","unstructured":"Arthur, D. V., S. in SODA \u201807: Proceedings of the Eighteenth Annual ACM-SIAM Symposium on Discrete Algorithms. 1027\u20131035."},{"key":"64662_CR88","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1109\/TIT.1982.1056489","volume":"28","author":"S Lloyd","year":"1982","unstructured":"Lloyd, S. Least Squares Quantization in PCM. IEEE Trans. Inf. Theory 28, 129\u2013137 (1982).","journal-title":"IEEE Trans. Inf. Theory"},{"key":"64662_CR89","unstructured":"Aly, M. Survey on multiclass classification methods. (California Institute of Technology, Caltech, 2005)."},{"key":"64662_CR90","unstructured":"Bishop, C. M. Pattern recognition and machine learning. (Springer, 2006)."},{"key":"64662_CR91","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.1093\/bioinformatics\/17.suppl_1.S316","volume":"17","author":"CH Yeang","year":"2001","unstructured":"Yeang, C. H. et al. Molecular classification of multiple tumor types. Bioinformatics 17, S316\u2013S322 (2001).","journal-title":"Bioinformatics"},{"key":"64662_CR92","doi-asserted-by":"publisher","first-page":"e112963","DOI":"10.1371\/journal.pone.0112963","volume":"9","author":"BJ Walker","year":"2014","unstructured":"Walker, B. J. et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One 9, e112963 (2014).","journal-title":"PLoS One"},{"key":"64662_CR93","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nmeth.3313","volume":"12","author":"AA Shishkin","year":"2015","unstructured":"Shishkin, A. A. et al. Simultaneous generation of many RNA-seq libraries in a single reaction. Nat. Methods 12, 323\u2013325 (2015).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64662-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64662-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64662-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T01:02:59Z","timestamp":1762563779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64662-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64662"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64662-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9673"}}